Found: 20
Select item for more details and to access through your institution.
Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 11, p. 1236, doi. 10.1002/ajh.25628
- By:
- Publication type:
- Article
Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 10, p. E342, doi. 10.1002/ajh.25232
- By:
- Publication type:
- Article
BCR-ABL1 kinase domain mutational analysis of CD34+ stem/progenitor cells in newly diagnosed CML patients by next-generation sequencing.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 10, p. 1016, doi. 10.1002/ajh.23794
- By:
- Publication type:
- Article
Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications.
- Published in:
- American Journal of Hematology, 2013, v. 88, n. 9, p. 790, doi. 10.1002/ajh.23508
- By:
- Publication type:
- Article
Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 3, p. 318, doi. 10.1002/ajh.21942
- By:
- Publication type:
- Article
The assessment of human organic cation transporter 1 ( hOCT1) mRNA expression in patients with chronic myelogenous leukemia is affected by the proportion of different cells types in the analyzed cell population.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 7, p. 525, doi. 10.1002/ajh.21722
- By:
- Publication type:
- Article
Persistent splenomegaly during imatinib therapy and the definition of complete hematological response in chronic myelogenous leukemia.
- Published in:
- American Journal of Hematology, 2010, v. 85, n. 5, p. 386, doi. 10.1002/ajh.21689
- By:
- Publication type:
- Article
Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 4, p. 251, doi. 10.1007/BF03262214
- By:
- Publication type:
- Article
Analysis of Mutations in the BCR-ABL1 Kinase Domain, Using Direct Sequencing.
- Published in:
- Molecular Diagnosis & Therapy, 2012, v. 16, n. 3, p. 163, doi. 10.1007/BF03262204
- By:
- Publication type:
- Article
Léčba pacientů s chronickou myeloidní leukemií - nečekaný anebo očekávaný průnik onkologie a vnitřního lékařství?
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2020, v. 66, n. 4, p. 2, doi. 10.36290/vnl.2020.073
- By:
- Publication type:
- Article
Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Hierarchical distribution of somatic variants in newly diagnosed chronic myeloid leukaemia at diagnosis and early follow‐up.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 604, doi. 10.1111/bjh.17659
- By:
- Publication type:
- Article
Novel Illumina‐based next generation sequencing approach with one‐round amplification provides early and reliable detection of BCR‐ABL1 kinase domain mutations in chronic myeloid leukemia.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 3, p. 469, doi. 10.1111/bjh.16382
- By:
- Publication type:
- Article
Elucidation of protein interactions necessary for the maintenance of the BCR–ABL signaling complex.
- Published in:
- Cellular & Molecular Life Sciences, 2020, v. 77, n. 19, p. 3885, doi. 10.1007/s00018-019-03397-7
- By:
- Publication type:
- Article
The predictive value of human organic cation transporter 1 and ABCB1 expression levels in different cell populations of patients with de novo chronic myelogenous leukemia.
- Published in:
- 2011
- By:
- Publication type:
- letter
Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 5, p. 1209, doi. 10.1007/s00262-022-03312-3
- By:
- Publication type:
- Article
No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia.
- Published in:
- Hematological Oncology, 2014, v. 32, n. 2, p. 87, doi. 10.1002/hon.2091
- By:
- Publication type:
- Article
The significance of enzyme and transporter polymorphisms for imatinib plasma levels and achieving an optimal response in chronic myeloid leukemia patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Tyrozinkinázové inhibitory v léčbě starších pacientů s chronickou myeloidní leukemií -- editorial.
- Published in:
- Internal Medicine / Vnitrni Lekarstvi, 2015, v. 61, n. 9, p. 760
- By:
- Publication type:
- Article